About this trial
The goal of this two-arm cluster randomised controlled trial (RCT) is to evaluate the effectiveness of a new implementation strategy based on the ImM model for the Protocol of assistance to the person with diabetic foot (PAPDF) of the Balearic Islands Health Service in reducing complications of diabetic foot, compared to the current implementation strategy, in the primary care centers of Majorca. As secondary objectives we aim 1. To determine the reach of the implementation strategy in the GAPM primary care centers, 2.To compare the effectiveness of the PAPDF versus usual care in preventing diabetic foot complications, 3. To identify the number of healthcare professionals adhering to the implementation strategy and 4. To assess the sustainability of the implementation strategy over time.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of type 1 or type 2 diabetes mellitus.
Aged 18 years or older.
Attending nursing consultations at participating primary care centers during the study period.
Disqualifiers
Patients with gestational diabetes.
Patients with diabetic foot ulcers prior to the start of the study.
Patients with lower limb amputations prior to the start of the study.
Trial design
Parallel
Treatments tested in this trial
Implementation strategy developed using the Implementation Mapping model to enhance the effective integration of the Protocol for Assistance to People with Diabetic Foot
BehavioralThe intervention will be based on the Implementation Mapping methodology (IM). This model is based on the Intervention Mapping. IM consists of several specific tasks: 1. Conduct an assessment of needs and identification of programme adopters and implementers through a review of qualitative or mixed studies assessing the perceptions of both patients and professionals regarding DF prevention as well as individual semi-structured interviews with patients, health professionals and management staff 2. Indicate adoption and implementation outcomes and action objectives, identifying determinants and create matrices of change; this process will allow for the identification of determinants, which are those factors that influence the actions will be implemented 3. Select theoretical methods and select or design implementation strategies using the ERIC model (Expert Recommendations for Implementing Change) 4. Produce implementation protocols and materials 5. Evaluate implementation results
Sham Comparator
Other interventionUsual care: No systematic implementation of the protocol based on the prevention of foot at risk, ulcer treatment and screening of the risk of diabetic foot ulcer for referral to hospital care.
Treatment groups
Trial outcomes
Primary outcomes
Reach
Percentage of patients with diabetes mellitus over 18 years of age who have the "Diabetic Foot Protocol" open in the electronic medical record divided by the total number of patients with DM over 18 years of age in the health centers of both groups.
Secondary outcomes
Effectiveness
Comparison of the prevalence of diabetic foot ulcers among patients older than 18 years with diabetes mellitus in both groups. As a secondary outcome, the prevalence of total lower limb amputations in DM patients older than 18 years will also be compared between the intervention group and the control group.
Adoption
Percentage of nurses who have performed the Diabetic Foot Protocol out of the total number of nurses in the center in both groups.
Implementation fidelity
Degree to which the implementation of the Diabetic Foot Protocol is delivered as intended in both groups. The number of completed protocols will be determined with respect to the total number of open protocols. A completed protocol will be understood as one in which all items have been recorded.
Maintenance
Measured through the Provider REport of Sustainment Scale (PRESS) in both groups. This validated scale consists of 3 items that are assessed on a Likert scale.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of the Balearic Islands
Lead sponsor
Universitat de les Illes Balears
Collaborator
This trial is not recruiting at the moment. You can still explore other options: